Logo image of SNEX

STONEX GROUP INC (SNEX) Stock Fundamental Analysis

NASDAQ:SNEX - Nasdaq - US8618961085 - Common Stock - Currency: USD

84.24  -0.91 (-1.07%)

After market: 84.5 +0.26 (+0.31%)

Fundamental Rating

3

SNEX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 232 industry peers in the Capital Markets industry. SNEX may be in some trouble as it scores bad on both profitability and health. SNEX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year SNEX was profitable.
In the past year SNEX has reported a negative cash flow from operations.
In the past 5 years SNEX has always been profitable.
The reported operating cash flow has been mixed in the past 5 years: SNEX reported negative operating cash flow in multiple years.
SNEX Yearly Net Income VS EBIT VS OCF VS FCFSNEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

Looking at the Return On Assets, with a value of 0.91%, SNEX is doing worse than 67.67% of the companies in the same industry.
SNEX has a Return On Equity of 15.19%. This is in the better half of the industry: SNEX outperforms 75.86% of its industry peers.
With a Return On Invested Capital value of 1.52%, SNEX is not doing good in the industry: 68.10% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for SNEX is significantly below the industry average of 7.87%.
Industry RankSector Rank
ROA 0.91%
ROE 15.19%
ROIC 1.52%
ROA(3y)0.99%
ROA(5y)0.96%
ROE(3y)16.74%
ROE(5y)16.85%
ROIC(3y)2.05%
ROIC(5y)1.73%
SNEX Yearly ROA, ROE, ROICSNEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

With a Profit Margin value of 0.23%, SNEX is not doing good in the industry: 73.28% of the companies in the same industry are doing better.
SNEX's Profit Margin has been stable in the last couple of years.
SNEX has a Operating Margin of 0.32%. This is in the lower half of the industry: SNEX underperforms 74.14% of its industry peers.
SNEX's Operating Margin has been stable in the last couple of years.
With a Gross Margin value of 1.97%, SNEX is not doing good in the industry: 73.28% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of SNEX has declined.
Industry RankSector Rank
OM 0.32%
PM (TTM) 0.23%
GM 1.97%
OM growth 3Y-1.36%
OM growth 5Y1.16%
PM growth 3Y-1.69%
PM growth 5Y-0.17%
GM growth 3Y-15.32%
GM growth 5Y-4.82%
SNEX Yearly Profit, Operating, Gross MarginsSNEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3 4

1

2. Health

2.1 Basic Checks

SNEX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SNEX has been increased compared to 5 years ago.
SNEX has a worse debt/assets ratio than last year.
SNEX Yearly Shares OutstandingSNEX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
SNEX Yearly Total Debt VS Total AssetsSNEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

An Altman-Z score of 3.67 indicates that SNEX is not in any danger for bankruptcy at the moment.
SNEX has a better Altman-Z score (3.67) than 79.74% of its industry peers.
SNEX has a Debt/Equity ratio of 7.19. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 7.19, SNEX is not doing good in the industry: 88.36% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 7.19
Debt/FCF N/A
Altman-Z 3.67
ROIC/WACCN/A
WACCN/A
SNEX Yearly LT Debt VS Equity VS FCFSNEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

SNEX has a Current Ratio of 0.52. This is a bad value and indicates that SNEX is not financially healthy enough and could expect problems in meeting its short term obligations.
SNEX has a Current ratio of 0.52. This is in the lower half of the industry: SNEX underperforms 75.00% of its industry peers.
SNEX has a Quick Ratio of 0.52. This is a bad value and indicates that SNEX is not financially healthy enough and could expect problems in meeting its short term obligations.
SNEX has a Quick ratio of 0.52. This is in the lower half of the industry: SNEX underperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.52
SNEX Yearly Current Assets VS Current LiabilitesSNEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

6

3. Growth

3.1 Past

SNEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.07%, which is quite good.
The Earnings Per Share has been growing by 22.13% on average over the past years. This is a very strong growth
Looking at the last year, SNEX shows a very strong growth in Revenue. The Revenue has grown by 67.71%.
The Revenue has been growing by 24.87% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)18.07%
EPS 3Y26.7%
EPS 5Y22.13%
EPS Q2Q%29.75%
Revenue 1Y (TTM)67.71%
Revenue growth 3Y32.92%
Revenue growth 5Y24.87%
Sales Q2Q%49.48%

3.2 Future

Based on estimates for the next years, SNEX will show a small growth in Earnings Per Share. The EPS will grow by 6.87% on average per year.
The Revenue is expected to grow by 2.62% on average over the next years.
EPS Next Y12%
EPS Next 2Y6.15%
EPS Next 3Y6.87%
EPS Next 5YN/A
Revenue Next Year7.01%
Revenue Next 2Y3.55%
Revenue Next 3Y2.62%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SNEX Yearly Revenue VS EstimatesSNEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B 80B
SNEX Yearly EPS VS EstimatesSNEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.28, which indicates a correct valuation of SNEX.
SNEX's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of SNEX to the average of the S&P500 Index (26.32), we can say SNEX is valued slightly cheaper.
SNEX is valuated correctly with a Price/Forward Earnings ratio of 14.09.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SNEX is on the same level as its industry peers.
SNEX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.28
Fwd PE 14.09
SNEX Price Earnings VS Forward Price EarningsSNEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SNEX is valued cheaper than 90.95% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.64
SNEX Per share dataSNEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K 1.5K 2K 2.5K

4.3 Compensation for Growth

SNEX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.19
PEG (5Y)0.65
EPS Next 2Y6.15%
EPS Next 3Y6.87%

0

5. Dividend

5.1 Amount

No dividends for SNEX!.
Industry RankSector Rank
Dividend Yield N/A

STONEX GROUP INC

NASDAQ:SNEX (6/13/2025, 8:00:02 PM)

After market: 84.5 +0.26 (+0.31%)

84.24

-0.91 (-1.07%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners82.48%
Inst Owner Change55.62%
Ins Owners10.11%
Ins Owner Change9.77%
Market Cap4.12B
Analysts87.5
Price Target104.04 (23.5%)
Short Float %2.51%
Short Ratio2.64
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.79%
Min EPS beat(2)4.76%
Max EPS beat(2)14.81%
EPS beat(4)4
Avg EPS beat(4)8.49%
Min EPS beat(4)3.43%
Max EPS beat(4)14.81%
EPS beat(8)8
Avg EPS beat(8)11.57%
EPS beat(12)11
Avg EPS beat(12)13.14%
EPS beat(16)13
Avg EPS beat(16)15.34%
Revenue beat(2)2
Avg Revenue beat(2)1.2%
Min Revenue beat(2)0.48%
Max Revenue beat(2)1.92%
Revenue beat(4)3
Avg Revenue beat(4)1.23%
Min Revenue beat(4)-3.69%
Max Revenue beat(4)6.22%
Revenue beat(8)5
Avg Revenue beat(8)-1.53%
Revenue beat(12)9
Avg Revenue beat(12)1100.01%
Revenue beat(16)13
Avg Revenue beat(16)1890.17%
PT rev (1m)22.89%
PT rev (3m)-20.31%
EPS NQ rev (1m)1.81%
EPS NQ rev (3m)-37.81%
EPS NY rev (1m)0%
EPS NY rev (3m)-33.02%
Revenue NQ rev (1m)-2.97%
Revenue NQ rev (3m)0.62%
Revenue NY rev (1m)-2.47%
Revenue NY rev (3m)1.79%
Valuation
Industry RankSector Rank
PE 14.28
Fwd PE 14.09
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B 2.19
P/tB 2.3
EV/EBITDA 7.64
EPS(TTM)5.9
EY7%
EPS(NY)5.98
Fwd EY7.1%
FCF(TTM)-23.01
FCFYN/A
OCF(TTM)-21.7
OCFYN/A
SpS2515.02
BVpS38.47
TBVpS36.63
PEG (NY)1.19
PEG (5Y)0.65
Profitability
Industry RankSector Rank
ROA 0.91%
ROE 15.19%
ROCE 6.01%
ROIC 1.52%
ROICexc 1.63%
ROICexgc 1.75%
OM 0.32%
PM (TTM) 0.23%
GM 1.97%
FCFM N/A
ROA(3y)0.99%
ROA(5y)0.96%
ROE(3y)16.74%
ROE(5y)16.85%
ROIC(3y)2.05%
ROIC(5y)1.73%
ROICexc(3y)2.29%
ROICexc(5y)1.95%
ROICexgc(3y)2.5%
ROICexgc(5y)2.13%
ROCE(3y)6.36%
ROCE(5y)5.86%
ROICexcg growth 3Y11.83%
ROICexcg growth 5Y4.45%
ROICexc growth 3Y11.82%
ROICexc growth 5Y4.25%
OM growth 3Y-1.36%
OM growth 5Y1.16%
PM growth 3Y-1.69%
PM growth 5Y-0.17%
GM growth 3Y-15.32%
GM growth 5Y-4.82%
F-Score4
Asset Turnover3.93
Health
Industry RankSector Rank
Debt/Equity 7.19
Debt/FCF N/A
Debt/EBITDA 27.95
Cap/Depr 72.81%
Cap/Sales 0.05%
Interest Coverage 0.3
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.52
Altman-Z 3.67
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)80.55%
Cap/Depr(5y)85.05%
Cap/Sales(3y)0.07%
Cap/Sales(5y)0.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.07%
EPS 3Y26.7%
EPS 5Y22.13%
EPS Q2Q%29.75%
EPS Next Y12%
EPS Next 2Y6.15%
EPS Next 3Y6.87%
EPS Next 5YN/A
Revenue 1Y (TTM)67.71%
Revenue growth 3Y32.92%
Revenue growth 5Y24.87%
Sales Q2Q%49.48%
Revenue Next Year7.01%
Revenue Next 2Y3.55%
Revenue Next 3Y2.62%
Revenue Next 5YN/A
EBIT growth 1Y20.39%
EBIT growth 3Y31.11%
EBIT growth 5Y26.32%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y62.25%
FCF growth 3Y-40.15%
FCF growth 5Y19.18%
OCF growth 1Y63.81%
OCF growth 3Y-37.96%
OCF growth 5Y20.98%